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Research highlights: 28 
 29 
1. Whiteleg shrimp Penaeus vannamei were bath challenged with Vibrio 30 
parahaemolyticus and shrimp had significantly greater survival in biofloc than clear 31 
seawater during 96 h post-challenge. 32 
 33 
2. Shrimp stocking density (1 to 5 shrimp per 400 mL) did not influence survival of 34 
shrimp bath challenged with V. parahaemolyticus in either biofloc or clear seawater 35 
conditions. 36 
 37 
3. Survival of shrimp bath challenged with V. parahaemolyticus was significantly 38 
greater in Nile tilapia-conditioned water prepared at 5 ppt and 10 ppt compared to at 15 ppt 39 
and in clear seawater at 5, 10 and 15 ppt. 40 
 41 
4.  Biofloc and Nile tilapia-conditioned water may protect against acute 42 
hepatopancreas necrosis disease (AHPND), and these are inexpensive potential disease 43 
management control strategies that could be adopted by the shrimp industry. 44 
 45 
Statement of relevance: 46 
 47 
Managed biofloc and Nile tilapia-conditioned water culture conditions can reduce whiteleg 48 
shrimp losses due to Vibrio parahaemolyticus (134 characters with spaces)  49 
 
 
 
Abstract  50 
 51 
Isolates of Vibrio parahaemolyticus (VpAHPND) that carry a plasmid encoding two Pir-like 52 
toxins cause acute hepatopancreatic necrosis disease (AHPND), a disease that has caused 53 
devastating economic losses to the shrimp industry, particularly in Asia. However, lower 54 
prevalence of AHPND infection has been associated with farms that operate with biofloc 55 
or lower salinity culture water. Therefore, the aim of this present study was to investigate 56 
the effects of biofloc, different culture water salinity and Nile tilapia (Oreochromis 57 
niloticus)-conditioned water on survival of whiteleg shrimp (Penaeus vannamei) bath 58 
challenged experimentally with VpAHPND. First, groups of shrimp were bath challenged 59 
with VpAHPND in clear 15 ppt seawater (CW) or in the presence of a pre-cultured biofloc at 60 
25%, 50% and 100% (v/v). Survival during 96 h post-challenge was significantly greater in 61 
groups cultured in 50% and 100% biofloc (p<0.05). In a second trial, the effect of shrimp 62 
stocking density on biofloc protection against bath challenge with VpAHPND was determined 63 
and shrimp challenged in 100% biofloc again had significantly greater survival (p<0.05) 64 
compared to the CW group, whilst under our experimental conditions stocking density had 65 
no significant influence on survival post-challenge. In a third trial, shrimp were challenged 66 
with VpAHPND in three different salinities of CW or Nile tilapia-conditioned (NTC) water (5 67 
ppt, 10 ppt and 15 ppt). Survival in this final trial was 33% at 96 h in 5 ppt CW compared 68 
to just 7% in the 10 ppt and the 15 ppt CW groups, though these differences were not 69 
statistically significant. Moreover, shrimp survival in the 5 ppt and 10 ppt NTC water 70 
groups was significantly greater than in the 15 ppt NTC water group (p<0.05), while 71 
significantly greater survival was observed in 10 ppt NTC water compared to 10 ppt CW 72 
(p<0.05). The results indicate that biofloc and NTC water may provide some protection 73 
against AHPND, whilst low salinity culture water may also offer a degree of protection 74 
against this bacterium. These findings may allow for the implementation of inexpensive 75 
strategies in the shrimp industry to assist in minimising the impact of VpAHPND as part of 76 
pond management practices.  77 
 
 
 
1. Introduction 78 
 79 
Infection of tiger shrimp (Penaeus monodon) and whiteleg shrimp (Penaeus vannamei) by 80 
pathogenic isolates of Vibrio parahaemolyticus that carry a plasmid encoding two Pir-like 81 
toxins can cause progressive degeneration of the hepatopancreas resulting in high 82 
mortalities of juvenile shrimp and often entire loss of stocks within 30 days (Lightner et 83 
al., 2012; Network of Aquaculture Centres Asia-Pacific [NACA], 2012; Zorriehzahra & 84 
Banaederakhshan, 2015). Since 2009 this infection, known as acute hepatopancreatic 85 
necrosis disease (AHPND), has resulted in collective losses exceeding an estimated US$ 86 
43 bn across Asia (China, Malaysia, Thailand, Vietnam) and in Mexico (Flegel, 2012; Tran 87 
et al., 2013; Chonsin et al., 2016; Pakingking et al., 2016; Office International des 88 
Epizooties [OIE], 2017; Shinn et al., in press b). AHPND infections, however, are also 89 
known in India (Ananda Raja et al., 2017), the Philippines (Dabu et al., 2015; de la Peña et 90 
al., 2015), Costa Rica and Honduras (Jun et al., 2016), while mortalities of P. monodon 91 
attributed to an AHPND-like condition have been reported from Cambodian ponds (Lang 92 
and Sothea, 2016). In Thailand, AHPND caused whiteleg shrimp production to reduce 93 
from ca. 600,000 tons in 2011 to ca. 200,000 tons by 2015. In turn, this meant that 94 
Thailand has been surpassed by Vietnam, China and India as the largest exporters of 95 
shrimp (Pakingking et al., 2016; Portley, 2016), and these differentials correlate positively 96 
with levels intensification in these countries, i.e. Vietnam, China and India retains a greater 97 
mix of less and more intensive culture systems with the former type being less impacted by 98 
AHPND.  99 
 100 
Lower prevalence of infection has been associated with lower salinity culture 101 
conditions,and use of biofloc systems and lined ponds (Gabaudan, 2012; NACA, 2012; De 102 
Schryver et al., 2014; Boonyawiwat et al., 2017). Juvenile shrimp, i.e. post-larvae (PL) 103 
stage 1 to PL stage 30, are reared typically in clear water with the addition of 104 
phytoplankton, zooplankton (Artemia sp.), commercial feeds and other supplementary 105 
feeds such as microalgae, e.g. Chaetoceros spp. (Suita, 2016). As detritivores, shrimp can 106 
also feed on biofloc, a flocculent, organic, protein-rich suspension consisting of 107 
prokaryotic and eukaryotic microbes. Moreover, the basic principle of a biofloc system is 108 
to recycle the ammonia and nitrite resulting from uneaten food and faeces into microbial 109 
biomass that can be used either in situ by the cultured animals as a source of protein or 110 
subsequently harvested and processed into a feed (Avnimelech, 1999; Hari et al., 2004; De 111 
 
 
 
Schryver et al., 2008; Kuhn et al., 2009; Crab et al., 2012; Avnimelech, 2014; Ekasari et 112 
al., 2014).  113 
 114 
The use of biofloc can increase feed utilization, growth, survival and the reproductive 115 
performance of cultured animals (Xu et al., 2012; Ekasari et al., 2014; Suita, 2016; 116 
Ballester et al., 2017). Moreover, some studies have investigated the beneficial 117 
immunological effects of the organisms found in biofloc, and their cellular components 118 
and metabolites can act as immunostimulants to enhance the shrimp innate immune system 119 
and provide improved protection against pathogens (Vazquez et al., 2009; Crab et al., 120 
2010; Ekasari et al., 2014; de Jesus Becerra-Dorame et al., 2014; Xu et al., 2014; Kim et 121 
al., 2014; Shinn et al., in press a). Critically, biofloc may also have a direct ‘probiotic’ 122 
effect in the pond or gut microbiome, i.e. as benign commensal heterotrophic bacteria with 123 
potential to displace pathogenic Vibrio spp. (facultative anaerobes) under intensively 124 
aerated production conditions (Arias-Moscoso et al., 2018) 125 
 126 
Production of biofloc is optimised through managed addition of organic carbon under 127 
highly aerated and minimal water-exchange culture conditions, and biofloc may be 128 
managed in or ex situ, i.e. directly with the target culture species or separately 129 
(Avnimelech, 1999). Biofloc systems are further differentiated as brown or green water 130 
systems contingent on lighting levels and thus the relative mix of ‘brown’ heterotrophic 131 
bacteria and ‘green’ phytoplankton (Taw, 2012). Hereafter, we differentiate between this 132 
interpretation and a more generalised use of ‘greenwater’ (conjoined) to describe any 133 
phytoplankton dominated culture system, with or (more typically in the case of tilapia 134 
culture) without aeration and lacking any directed carbon:nitrogen management. 135 
 136 
Biofloc and greenwater approaches to culture shrimp precede the recent emergence of 137 
AHPND-causing strains of V. parahaemolyticus (VpAHPND) in many places (Hargreaves, 138 
2013) but, in the Philippines and Vietnam, greenwater technology has been adopted 139 
alongside improved biosecurity practices at grow-out pond sites to prevent AHPND (Usero 140 
& Apostol-Albaladejo, 2015; Cadiz et al., 2016; Pakingking, 2016). Since 1996, tilapia-141 
conditioned water with a high Chlorella content has been used in shrimp farming to 142 
prevent Vibrio spp. infections (Dash et al., 2017). Meanwhile, bacteria isolated from tilapia 143 
skin and mucus from the gut and skin  have demonstrated potent anti-Vibrio spp. properties 144 
(Lio-Po et al., 2005). Aside from reducing the burden of certain bacteria in the water, co-145 
 
 
 
culture of tilapia in shrimp ponds is recommended for improving soil and water quality 146 
(Tendencia et al., 2015). Tendencia et al. (2004, 2015) reported that rearing tilapia at >300 147 
g m-3 inhibited the growth of Vibrio spp. in shrimp biomass stocked at 80 g m-3 and 148 
improved shrimp survival.  149 
 150 
This present study aimed to investigate the effects of biofloc and Nile tilapia (Oreochromis 151 
niloticus)-conditioned (NTC) water prepared at different salinities to protect whiteleg 152 
shrimp against experimental bath challenge with a pathogenic VpAHPND isolate. 153 
 154 
2. Materials and methods 155 
 156 
2.1 Bacteria, shrimp and tilapia 157 
 158 
The VpAHPND isolate FVG0001 was used for all challenge trials. During May to June 2017, 159 
batches of juvenile whiteleg shrimp were acquired from a commercial shrimp hatchery 160 
located in Chachoengsao Province, Thailand, and transferred to the quarantine unit at the 161 
Fish Vet Group Asia Limited (FVGAL) Research Aquarium in Chonburi, Thailand. On 162 
receipt of each shipment, the shrimp were surface-disinfected with 0.1 mg L-1 povidone 163 
iodine and a sub-sample (n = 20 individuals; mean of 0.4 g) were confirmed to be negative 164 
for seven major shrimp diseases (VpAHPND; the microsporidian Enterocytozoon 165 
hepatopenaei [EHP]; infectious hypodermal and haemotopoietic necrosis virus [IHHNV]; 166 
infectious myonecrosis virus [IMNV]; Taura syndrome virus [TSV]; white-spot syndrome 167 
virus [WSSV]; and, yellow head virus [YHV]) by iiPCR test kits (GeneReach 168 
Biotechnology Corporation, Taichung, Taiwan) and OIE approved methodologies (OIE, 169 
2017). Furthermore, 24 mixed sex Nile tilapia were sourced from a commercial farm 170 
(119.8 ± 33.4 g) and transferred to the FVGAL Diagnostic Laboratory (ca. 2 km from the 171 
FVGAL Research Aquarium).  172 
 173 
2.2 Shrimp holding conditions and preparation of biofloc 174 
 175 
Disease-free shrimp were stocked into 400-L tanks (positioned out of direct sunlight) 176 
containing mature biofloc. The biofloc in each tank had been established in 300 L of 15 ppt 177 
seawater. This water had been pre-treated with 50 mg L-1 chlorine and then treated with a 178 
further 10 mg L-1 chlorine for at least 1 h by addition of calcium hypochlorite, with any 179 
 
 
 
residual chlorine driven off with vigorous aeration. Absence of residual chlorine was 180 
confirmed using an orthotolidine-based chlorine test kit (Monitor®; Pet Wonderland 181 
Group, Thailand). The biofloc was initiated by adding 5 g rice bran, 1.5 g ground shrimp 182 
feed and 3 g white sugar (as sources of carbon) to each tank and incubating for 2 days at 183 
28–29°C with intensive aeration (this provided greenwater biofloc given the ambient 184 
lighting typical of sub-tropical shrimp pond production conditions). Thereafter, 1 g ground 185 
shrimp feed and 3 g white sugar were added on a daily basis. At day 3, physicochemical 186 
water parameters were measured in situ and adjusted by changing rates of carbon substrate 187 
addition to adhere within the following limits: <0.03 mg L-1 ammonia and <1 mg L-1 nitrite 188 
(measured with a TetraTM test kit; Tetra GmbH, Melle, Germany), pH 7.5–8.0 (maintained 189 
through the addition of calcium carbonate as necessary), alkalinity 80-150 mg L-1 CaCO3, 190 
15 ppt salinity and 28–29°C (measured using a hand-held automatic temperature 191 
compensation refractometer; Bellingham & Stanley Ltd, United Kingdom), and >5 mg L-1 192 
dissolved oxygen (DO) (measured with a hand-held DO meter; YSI 550A; Xylem Inc., 193 
United States). A system of inverted air pipes provided continuous aeration to maintain 194 
DO at >5 mg L-1 and salinity, DO and temperature readings were taken daily thereafter. 195 
The shrimp were maintained on commercial feed (Starbird 5093 S shrimp feed; Charoen 196 
Pokphand Co., Bangkok, Thailand) at 10% body wt d-1, given daily in three equal rations 197 
at 08:00, 14:00 and 18:00. Additionally, white sugar was added at a ratio of white 198 
sugar:shrimp feed (2.3:1). The condition of the shrimp and biofloc were monitored 199 
microscopically every day to ensure that the shrimp were in good condition (i.e., no 200 
evidence of necrosis, biofouling or infection of the shrimp). The biofloc was considered to 201 
be ready for application when Imhoff cone readings were >10 ml L-1 after a 30-min 202 
settlement period, and 10–15 mL L-1 is considered ideal for shrimp culture (Hargreaves, 203 
2013). Total suspended solids readings were confirmed by filtering 1 L of biofloc 204 
suspension through pre-weighed filter paper (Whatman No. 93; GE Healthcare UK 205 
Limited, Buckinghamshire, UK) and then drying for 24 h at 50°C before massing the dried 206 
matter. Biofloc was collected at >14 d and used for the experimental challenge trials. 207 
Generally, 10–15% of the water volume was exchanged daily with pre-treated and 208 
dechlorinated 15 ppt seawater (except for the day prior to the start of a challenge trial to 209 
preserve the condition of the biofloc); however, volume exchanges deviated occasionally 210 
to ensure Imhoff cone readings were maintained at 10–15 mL L-1.  211 
 212 
2.3 Tilapia holding conditions and preparation of NTC water 213 
 
 
 
 214 
The tilapia were stocked into a single 600-L aerated (70 L min-1) tank containing 215 
dechlorinated freshwater (partially shaded from direct sunlight) and allowed to acclimate 216 
for 7 days. Water temperature (32.1 ± 2.6 °C) and surface light (mean intensity of 60,346 217 
lux d-1 [maximum = 297,602 lux d-1] and mean duration of 12.91 ± 0.18 h sunlight d-1 218 
[range: 12.5–13 h d-1]) was recorded every 15 min with data loggers (Onset HOBO UA-219 
001-64; Bourne, MA, USA). After acclimation, the fish were split such that 8 fish were 220 
assigned at random to each of three 200-L tanks (biomass of ca. 960 g tank-1). Aeration 221 
was then split between the three tanks, while DO, pH, ammonia and nitrate were measured 222 
daily and adjusted where necessary to maintain >5 mg L-1 DO, 7.5–8.0 pH, <0.03 mg L-1 223 
ammonia and <1 mg L-1 nitrite. Salinity and temperature were also measured daily. 224 
Salinity in each tank was adjusted at a rate of 2 ppt each day until salinities of 5 ppt, 10 ppt 225 
and 15 ppt were achieved. The fish were maintained on a 2% body wt d-1 feeding regime 226 
using a commercial pelleted feed (CP 9921; Charoen Pokphand Co., Bangkok, Thailand) 227 
for >14 d before the NTC water was collected and used for the experimental challenge 228 
trials. At collection, the chlorophyll a content of each tank was determined from 1-L 229 
samples collected in acid-washed polyethylene bottles and analysed by the Institute of 230 
Marine Science at Burapha University (Chonburi, Thailand) following the procedure 231 
described by Strickland & Parsons (1972). The chlorophyll a concentration of the NTC 232 
water was determined to be 1,150 mg m-3 (5 ppt), 1,917 mg m3 (10 ppt) and 1,292 mg m3 233 
(15 ppt). Meanwhile, total suspended solids in 1 L from each tank was determined by 234 
Imhoff cone (readings were between 11–15 mL L-1) and filtering as described above, and 235 
the dry weight of organic material from each of the three tanks was 4.7 mg L-1 (5 ppt), 6.8 236 
mg L-1 (10 ppt) and 4.9 mg L-1 (15 ppt).  237 
 238 
2.4 Preparation for shrimp bath challenge with VpAHPND 239 
 240 
The inoculum for the challenge trial was prepared by inoculating the VpAHPND isolate 241 
FVG0001 into tryptone soya broth (TSB) supplemented with 2% NaCl and culturing for 12 242 
h at 28°C with shaking (ca. 250 rpm). Bacterial cells were collected by centrifugation at 243 
900 ×g for 10 min at 10°C and then the bacterial pellet was re-suspended in sterile 15 ppt 244 
seawater. The number of colony-forming units (CFU) mL-1 in the suspension was 245 
estimated by measuring the optical density at 600 nm (OD600), as an OD600 of 1.0 AU 246 
equated to ca. 3.0×108 CFU mL-1. The suspension was adjusted to the desired OD600 (=1.0 247 
 
 
 
AU) with sterile 15 ppt seawater, and then CFU mL-1 verified by diluting and plating 248 
suspensions across tryptone soya agar and incubating at 28°C until CFU could be 249 
enumerated. Each challenge trial was performed in 1-L vessels and the quantity of bacteria 250 
required for each challenge was determined from virulence pre-tests performed typically 251 
<48 h earlier. Each virulence pre-test was conducted on shrimp from the same population 252 
intended for use in the trial and under the same conditions as the actual challenge. The pre-253 
tests used a minimum of three bacterial concentrations and three individually-housed 254 
shrimp per dose to determine the CFU mL-1 required to give ca. 66% mortality at 48 h 255 
post-infection. For all challenge trials, a semi-randomised block design was used to 256 
allocate the test vessels on the benching within the challenge room; however, the negative 257 
(non-challenged) control shrimp vessels were isolated on a separate bench to minimise 258 
potential cross-contamination. 259 
 260 
2.5 Trial 1: Effect of biofloc on survival of shrimp bath challenged with VpAHPND  261 
 262 
Shrimp (0.36 ± 0.12 g) were maintained in clear 15 ppt seawater (CW) for ≥7 days prior to 263 
challenge in 200-L tanks. The day before the challenge, the shrimp were transferred to 264 
static 1-L glass vessels in a temperature-controlled challenge room maintained at 27.2 ± 265 
0.2°C and monitored every 15 min with data loggers (Onset HOBO UA-001-64) placed 266 
inside two additional glass vessels in the challenge room. Then 3 shrimp were placed into 267 
each 1-L glass vessel containing 400 mL of 25%, 50% or 100% (v/v) biofloc, where 100% 268 
biofloc was from a 14-day old culture, with an Imhoff cone reading of 11 mL L-1 (0.54 g 269 
dry matter [DM] L-1). Each vessel was aerated at ca. 5 L min-1. From the virulence pre-test, 270 
3.2 mL of Vp inoculum was added to each challenge group vessel. Then the shrimp were 271 
monitored for survival every 3 h up to 96 h and mortalities were recorded and carcasses 272 
removed. At 24 h, a further 400 mL of the appropriate culture medium was added to each 273 
vessel (i.e., 15 ppt CW or a biofloc suspension as appropriate) and shrimp were fed ad 274 
libitum with commercial feed (Starbird 5093 S shrimp feed). At 48 h and 72 h, 400 mL of 275 
tank water was removed and replaced with 400 mL of appropriate culture medium. In total, 276 
15 replicates per treatment were prepared in addition to 15 negative (non-challenged) 277 
control vessels. 278 
 279 
2.6 Trial 2: Effect of shrimp stocking density on biofloc-conferred survival of shrimp bath 280 
challenged with VpAHPND  281 
 
 
 
 282 
Earlier studies have reported correlation between shrimp stocking density and increased 283 
risk of AHPND (Boonyawiwat et al., 2017; OIE, 2018). As before, shrimp (0.36 ± 0.12 g) 284 
were maintained in 15 ppt CW for ≥7 days prior to challenge. Then the shrimp were 285 
transferred into 1-L glass vessels containing 400 mL of 50% or 100% biofloc at 1, 3 or 5 286 
shrimp per vessel (temperature and aeration conditions as described in Section 2.5). In 287 
addition, a positive control group was prepared such that these vessels contained a single 288 
shrimp in 15 ppt CW and were challenged with VpAHPND. From the virulence pre-test 289 
(single shrimp held in 50% biofloc in this case), 6.2 mL Vp inoculum was added to each 290 
challenge group vessel. Shrimp survival was determined as described in Section 2.5, while 291 
culture medium exchange was also performed as before. In total, 10 replicates per 292 
treatment were prepared in addition to 10 negative (non-challenged) control vessels.  293 
 294 
2.7 Trial 3: Effect of Nile tilapia-conditioned water at different salinities on survival of 295 
shrimp bath challenged with VpAHPND  296 
 297 
Shrimp (0.36 ± 0.12 g) were maintained in three salinities of CW (5 ppt, 10 ppt and 15 ppt) 298 
for 14 days prior to challenge, and then transferred into 1-L glass vessels (1 shrimp per 299 
vessel) containing 400 mL of 5 ppt, 10 ppt or 15 ppt CW or 5 ppt, 10 ppt or 15 ppt NTC 300 
water (to avoid salinity shock the shrimp were transferred to identical salinity conditions). 301 
Temperature and aeration conditions of the vessels were as described in Section 2.5. From 302 
the virulence pre-test, 3.2 mL Vp inoculum was added to each challenge group vessel, and 303 
again culture medium exchange was performed as described in Section 2.5. In total, 10 304 
replicates per treatment were prepared in addition to an equivalent number of negative 305 
(non-challenged) control vessels. 306 
 307 
2.8 Disposal of experimental materials  308 
 309 
On completion of each trial, all remaining shrimp were euthanized in icy water and 310 
incinerated. All glass vessels and tank water were sterilised with 70 mg L-1 calcium 311 
hypochlorite for ≥24 h. Thereafter, the water was dechlorinated, airlines and airstones were 312 
discarded, while glass vessels were scrubbed, rinsed and allowed to dry. 313 
 314 
2.9 Ethics statement 315 
 
 
 
 316 
These experiments were reviewed by and conducted under the approval of the University 317 
of Stirling Animal Welfare and Ethical Review Body and the FVGAL internal ethical 318 
review board. Scientists conducting aquatic pathogen trials at FVGAL Research Aquarium 319 
hold licences for the use of “Animals for Scientific Purposes” issued by the Institute for 320 
Animals for Scientific Purpose Development, National Research Council of Thailand. The 321 
FVGAL laboratories and challenge facilities are registered with the relevant authorities and 322 
are inspected as required under current Thai legislation. 323 
 324 
2.10 Statistical analysis  325 
 326 
Survival in each shrimp group was plotted for each trial and Mantel-Cox log-rank tests 327 
(two-way) were performed to determine whether significant differences existed in survival 328 
between groups. A statistically significant difference was accepted at p<0.05 and Holm’s 329 
correction was applied to account for multiple comparisons (Holm, 1979).  330 
 331 
3. Results  332 
 333 
3.1 Trial 1: Effect of biofloc on survival of shrimp bath challenged with VpAHPND  334 
 335 
In the trial to determine whether different concentrations of biofloc would protect against a 336 
bath challenge with VpAHPND, few mortalities were observed in the non-challenged control 337 
groups (Figure 1). Indeed, no significant differences existed in shrimp survival between the 338 
15 ppt CW control and each control group maintained in 25%, 50% and 100% biofloc 339 
(p>0.05; Figure 1), thus indicating neither 15 ppt CW nor biofloc affected shrimp survival 340 
per se. 341 
 342 
For shrimp challenged with VpAHPND, greatest mortality was observed for those maintained 343 
in 15 ppt CW (60% mortality at 96 h post-challenge; Figure 1), which confirmed that the 344 
VpAHPND challenge had been successful. Importantly, there was significantly greater 345 
survival during 96 h post-challenge for shrimp maintained in 50% and 100% biofloc 346 
compared to those maintained in 15 ppt CW (p<0.05; Figure 1). 347 
 348 
 
 
 
3.2 Trial 2: Effect of shrimp stocking density on biofloc-conferred survival of shrimp bath 349 
challenged with VpAHPND 350 
In the trial to determine whether shrimp stocking density affected biofloc protection 351 
against a bath challenge with VpAHPND, few mortalities were observed in the non-352 
challenged control groups and no significant differences existed in percentage shrimp 353 
survival between the 15 ppt CW control (1 shrimp per vessel) and each control group 354 
maintained in 25%, 50% and 100% biofloc and containing 1, 3 or 5 shrimp per vessel 355 
(p>0.05; Figure 2), which again indicated that neither 15 ppt CW nor biofloc affected 356 
shrimp survival per se at any of the stocking densities. 357 
 358 
For shrimp challenged with VpAHPND, the greatest percentage mortality was observed for 359 
shrimp maintained in 15 ppt CW (100% mortality at 33 h post-challenge; Figure 2), which 360 
confirmed that the VpAHPND challenge had been successful. There was significantly greater 361 
survival during 96 h post-challenge for shrimp maintained in 100% biofloc (1 shrimp per 362 
vessel) compared to the 15 ppt CW (1 shrimp per vessel) group (p<0.05); however, there 363 
was no difference in survival between the 50% biofloc (1 shrimp per vessel) and 15 ppt 364 
CW (1 shrimp per vessel) groups (p>0.05; Figure 2). The absence of a protective effect by 365 
the 50% biofloc compared to the first trial where a significant enhancement in survival was 366 
observed compared to shrimp challenged in CW may be due to the greater dose of bacteria 367 
used in this second trial (means of 2.65 and 4.47 ×106 CFU mL-1 in trials 1 and 2, 368 
respectively). Furthermore, shrimp density in the vessels did not influence shrimp survival 369 
during 96 h post-challenge, as there were no significant differences between the 50% 370 
biofloc group containing 1 shrimp per vessel and the 50% biofloc groups containing either 371 
3 or 5 shrimp per vessel, or between the 100% biofloc group containing 1 shrimp per 372 
vessel and the 100% biofloc groups containing either 3 or 5 shrimp per vessel (p>0.05; 373 
Figure 2). 374 
 375 
3.3 Trial 3: Effect of Nile tilapia-conditioned water at different salinities on survival of 376 
shrimp bath challenged with VpAHPND 
 377 
 378 
In the trial to determine whether NTC water at different salinities could protect against a 379 
bath challenge with VpAHPND, again few mortalities were recorded in non-challenged 380 
control groups (Figure 3). There were no significant differences in shrimp survival 381 
between the 5 ppt, 10 ppt and 15 ppt CW control groups (p>0.05), or between the 5 ppt, 10 382 
 
 
 
ppt and 15 ppt NTC water control groups (p>0.05), or when comparing each 5 ppt, 10 ppt 383 
and 15 ppt CW control group with each respective salinity NTC water control group 384 
(p>0.05). These observations for the non-challenged control groups indicate that neither 385 
salinity nor the NTC water affected shrimp survival per se. 386 
 387 
For shrimp challenged with VpAHPND, there was no significant differences in shrimp 388 
survival between 5 ppt, 10 ppt and 15 ppt CW groups (p>0.05), though this may be due to 389 
the stringency of our statistical analyses because survival in the 5 ppt CW group was much 390 
greater at 96 h (33%) compared to the 10 ppt and the 15 ppt CW groups (both 7%). 391 
Moreover, shrimp survival in the 5 ppt and 10 ppt NTC water groups was significantly 392 
greater than in the 15 ppt NTC water group (p<0.05; Figure 3). Indeed, it is interesting that 393 
there were no significant differences (p>0.05) in shrimp survival between the 5 ppt CW 394 
and 5 ppt NTC water groups (relatively high survival of 33% and 80%, respectively) or 395 
between the 15 ppt CW and 15 ppt NTC water groups (relatively low survival of 7% and 396 
13%, respectively). Taken together, these observations indicate that low salinity may in 397 
itself provide a degree of protection against a bath challenge with VpAHPND. Furthermore, 398 
and confirming the trend of a protective effect of NTC water against a bath challenge with 399 
VpAHPND, significantly greater shrimp survival was confirmed in the 10 ppt NTC water 400 
group compared to the 10 ppt CW group (p<0.05; Figure 3). 401 
 402 
4. Discussion 403 
 404 
This present study aimed to investigate the effects of biofloc and NTC water prepared at 405 
different salinities to protect whiteleg shrimp against an experimental bath challenge with a 406 
pathogenic VpAHPND isolate. Shrimp challenged with VpAHPND in biofloc and NTC water 407 
prepared at 10 ppt had significantly increased survival during 96 h post-challenge. 408 
 409 
In the first trial, a direct relationship was found to exist between biofloc concentration and 410 
shrimp survival post-challenge with VpAHPND, and 50% and 100% biofloc (14-day old 411 
culture; dry weight of 0.54 g L-1) provided significant protection, which is in agreement 412 
with an earlier study performed under similar conditions (Shinn et al., in press a). 413 
Moreover, the observations are in line with other reports that demonstrate biofloc to be 414 
beneficial against shrimp pathogens, possibly through probiotic or immunostimulatory 415 
effects as distinct from simply reducing the probability of exposure to pathogens through 416 
 
 
 
operating a very low-water exchange system (Crab et al., 2010; Haslun et al., 2012; Moss 417 
et al., 2012; Zhao et al., 2012, Dash et al., 2017). Excessive biofloc concentrations might 418 
exert detrimental effects on shrimp health, e.g. by causing a reduction in gill function, 419 
biofouling of the carapace and induction of a stressful state; however, our findings 420 
demonstrate potential for highly effective protection against VpAHPND at relatively low 421 
biofloc concentrations (e.g., < 0.6 g DM L-1). Furthermore, prophylactic biofloc treatment 422 
limited to the most AHPND-sensitive first 30 days of shrimp culture may also preclude 423 
biofloc build-up and instability problems associated with extended culture and elevated 424 
feed inputs under closed production conditions (Little et al., 2008). In addition, this 425 
prophylactic approach would also support policy objectives to reduce antimicrobial usage 426 
in intensive shrimp culture, linked to food safety and antimicrobial resistance concerns. 427 
Notably, a number of studies have reported on antimicrobial-resistant strains of V. 428 
parahaemolyticus (Han et al., 2007; Lai et al., 2015; Saifedden et al., 2016) 429 
 430 
A further aim of this present study was to investigate whether NTC water was effective to 431 
protect whiteleg shrimp against a VpAHPND challenge. Farming shrimp at lower salinity has 432 
been associated with reduced risk of an AHPND outbreak (Gabaudan, 2012; NACA, 433 
2012). However, little information is available regarding whether different salinities of 434 
tilapia-conditioned water exert differential effects on bacterial pathogens such as VpAPHND. 435 
In this present study, NTC water prepared at 10 ppt increased shrimp survival significantly 436 
during 96 h post-challenge with VpAHPND compared to the 10 ppt CW control, thus 437 
confirming a protective effect of the NTC water against VpAPHND. The protection afforded 438 
by the NTC water at 10 ppt could be due to the microbial community in this milieu, as 439 
microorganisms with anti-Vibrio effects have been isolated from tilapia skin and gut 440 
mucus and from NTC water shrimp ponds (Lio-Po et al., 2005; Dash et al., 2017). 441 
Nevertheless, DM and chlorophyll a concentrations in the 10 ppt NTC water were greater 442 
than in the 5 ppt and 15 ppt NTC water, and this additional material may explain the 443 
greater survival of the shrimp in this group. Interestingly, the shrimp groups challenged in 444 
5 ppt and 10 ppt NTC water had significantly greater survival than in the 15 ppt group, and 445 
it could be that the different NTC waters were composed of distinct microbial communities 446 
with differential effects on VpAPHND and shrimp. Meanwhile, the 5 ppt CW group had 447 
greater survival than the 10 ppt and the 15 ppt CW groups, though no significant difference 448 
was detected but, taken in conjunction with the NTC water observations, the findings 449 
suggest that low water salinity may provide some protection against VpAHPND, which is 450 
 
 
 
worthy of further investigation. The results suggest that tilapia-conditioned water at low 451 
salinity could be employed as a strategy to reduce incidence of AHPND. 452 
 453 
One shortcoming of the present study is that the shrimp challenged in the biofloc 454 
conditions continued to feed throughout the trial, whereas those challenged in CW did not, 455 
meaning that the shrimp in biofloc would have had a better nutritional status and thus 456 
likely to be less susceptible to infection by VpAPHND. Furthermore, the data from this 457 
present study do not allow for determining whether the biofloc and NTC water led to 458 
increased survival of challenged shrimp through stimulating the immune response or direct 459 
inactivation of the pathogen. As the VpAPHND bacterium was introduced concurrently with 460 
the biofloc or NTC water, antibacterial effects perhaps explain the protective effects on 461 
shrimp survival because immunostimulation would be expected to take longer to take 462 
effect, though this requires experimental confirmation. Therefore, follow up studies should 463 
examine the direct effects of biofloc, NTC water and water salinity on the VpAHPND 464 
bacterium, such as reductions in cell division rates and viability, because these data may 465 
reveal the mechanisms underlying the increased shrimp survival. Importantly, the 466 
experimental VpAPHND challenge used may not well mimic what happens in the culture 467 
ponds where there is a slow build-up of bacteria, and therefore the development of 468 
improved challenge models that more closely reflect field conditions is warranted. Finally, 469 
the Nile tilapia and whiteleg shrimp used in the NTC water trial were gradually adjusted to 470 
the desired salinities at a rate of 2 ppt each day and the stress of this procedure may have 471 
impacted subsequent shrimp survival and this requires further investigation. Indeed, the 472 
population of whiteleg shrimp used in this present study was reared at 15 ppt from PL 473 
stage 14, and it would be interesting to rear shrimp at 5 ppt, 10 ppt and 15 ppt and repeat 474 
the trial to see if further survival improvements could be achieved.  475 
 476 
In conclusion, NTC water prepared at 10 ppt and biofloc protected whiteleg shrimp against 477 
experimental bath challenge with a pathogenic VpAHPND isolate. This suggests that 478 
inexpensive strategies could be developed by the shrimp industry that would reduce the 479 
impact of VpAHPND. 480 
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 741 
Figure 1. Survival of Penaeus vannamei bath challenged with the pathogenic AHPND-causing Vibrio parahaemolyticus isolate FVG0001 in 742 
clear 15 ppt seawater (CW) or biofloc (BF) at 25%, 50% and 100% (v/v) at 28–29°C in 1-L vessels containing 3 shrimp per vessel. n=15 vessels 743 
per group.  744 
 745 
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 747 
Figure 2. Survival of Penaeus vannamei bath challenged with the pathogenic AHPND-causing Vibrio parahaemolyticus isolate FVG0001 in 748 
clear 15 ppt seawater (CW) or biofloc (BF) at 50% and 100% (v/v) at 28–29°C in 1-L vessels containing 1, 3 and 5 shrimp per vessel. n=10 749 
vessels per group. 750 
 751 
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 754 
Figure 3. Survival of Penaeus vannamei bath challenged with the pathogenic AHPND-causing Vibrio parahaemolyticus isolate FVG0001 in 755 
clear seawater (CW) at 5 ppt, 10 ppt and 15 ppt or Nile tilapia-conditioned (NTC) water at 5 ppt, 10 ppt and 15 ppt at 28–29°C in 1-L vessels 756 
containing 1 shrimp per vessel. n=10 vessels per group. 757 
 758 
 759 
 
